Loading...
XCSEAMBUb
Market cap3.93bUSD
Dec 20, Last price  
106.30DKK
1D
0.38%
1Q
-19.53%
Jan 2017
87.48%
Name

Ambu A/S

Chart & Performance

D1W1MN
XCSE:AMBUb chart
P/E
167.17
P/S
5.88
EPS
0.64
Div Yield, %
0.00%
Shrs. gr., 5y
1.02%
Rev. gr., 5y
12.88%
Revenues
5.39b
+12.90%
653,908,000715,861,000715,024,000784,445,000876,931,000939,688,000982,812,0001,045,457,0001,383,000,0001,584,000,0001,889,000,0002,084,000,0002,355,000,0002,606,000,0002,820,000,0003,567,000,0004,013,000,0004,444,000,0004,775,000,0005,391,000,000
Net income
235m
+39.88%
37,692,00048,415,00042,777,00050,011,00055,764,00084,055,00069,213,000114,713,00048,000,000151,000,000152,000,000250,000,000301,000,000337,000,000317,000,000241,000,000247,000,00093,000,000168,000,000235,000,000
CFO
813m
+56.95%
40,126,00098,442,00088,306,00084,465,000113,015,00098,655,000102,071,000157,625,000122,000,000183,000,000208,000,000369,000,000462,000,000554,000,000533,000,000295,000,000328,000,00095,000,000518,000,000813,000,000
Dividend
Dec 15, 20210.29 DKK/sh
Earnings
Jan 28, 2025

Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
URL
https://www.ambu.com/
IPO date
Mar 09, 1992
Employees
4,500
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
5,391,000
12.90%
4,775,000
7.45%
4,444,000
10.74%
Cost of revenue
4,776,000
4,473,000
4,322,000
Unusual Expense (Income)
NOPBT
615,000
302,000
122,000
NOPBT Margin
11.41%
6.32%
2.75%
Operating Taxes
65,000
42,000
16,000
Tax Rate
10.57%
13.91%
13.11%
NOPAT
550,000
260,000
106,000
Net income
235,000
39.88%
168,000
80.65%
93,000
-62.35%
Dividends
(74,000)
Dividend yield
0.44%
Proceeds from repurchase of equity
1,091,000
12,000
BB yield
-5.67%
-0.07%
Debt
Debt current
75,000
72,000
79,000
Long-term debt
1,041,000
1,096,000
2,361,000
Deferred revenue
Other long-term liabilities
14,000
9,000
19,000
Net debt
501,000
1,096,000
(2,588,000)
Cash flow
Cash from operating activities
813,000
518,000
95,000
CAPEX
(289,000)
(326,000)
(558,000)
Cash from investing activities
(289,000)
(326,000)
(558,000)
Cash from financing activities
(65,000)
(222,000)
586,000
FCF
576,000
1,137,000
(1,538,000)
Balance
Cash
615,000
157,000
187,000
Long term investments
(85,000)
4,841,000
Excess cash
345,450
4,805,800
Stockholders' equity
5,347,000
5,393,000
4,261,000
Invested Capital
5,820,550
5,986,000
1,847,000
ROIC
9.32%
6.64%
7.70%
ROCE
9.97%
5.04%
1.99%
EV
Common stock shares outstanding
267,045
260,656
254,426
Price
131.15
77.57%
73.86
11.20%
66.42
-65.02%
Market cap
35,023,011
81.92%
19,252,052
13.92%
16,898,975
-64.86%
EV
35,524,011
20,348,052
14,310,975
EBITDA
979,000
650,000
473,000
EV/EBITDA
36.29
31.30
30.26
Interest
27,000
61,000
32,000
Interest/NOPBT
4.39%
20.20%
26.23%